10-45435337-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000698.5(ALOX5):​c.982-5093T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.755 in 151,554 control chromosomes in the GnomAD database, including 43,743 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.76 ( 43743 hom., cov: 29)

Consequence

ALOX5
NM_000698.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -3.07

Publications

9 publications found
Variant links:
Genes affected
ALOX5 (HGNC:435): (arachidonate 5-lipoxygenase) This gene encodes a member of the lipoxygenase gene family and plays a dual role in the synthesis of leukotrienes from arachidonic acid. The encoded protein, which is expressed specifically in bone marrow-derived cells, catalyzes the conversion of arachidonic acid to 5(S)-hydroperoxy-6-trans-8,11,14-cis-eicosatetraenoic acid, and further to the allylic epoxide 5(S)-trans-7,9-trans-11,14-cis-eicosatetrenoic acid (leukotriene A4). Leukotrienes are important mediators of a number of inflammatory and allergic conditions. Mutations in the promoter region of this gene lead to a diminished response to antileukotriene drugs used in the treatment of asthma and may also be associated with atherosclerosis and several cancers. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000698.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.858 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000698.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALOX5
NM_000698.5
MANE Select
c.982-5093T>C
intron
N/ANP_000689.1P09917-1
ALOX5
NM_001320861.2
c.982-5093T>C
intron
N/ANP_001307790.1
ALOX5
NM_001256153.3
c.982-5093T>C
intron
N/ANP_001243082.1P09917-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALOX5
ENST00000374391.7
TSL:1 MANE Select
c.982-5093T>C
intron
N/AENSP00000363512.2P09917-1
ALOX5
ENST00000542434.5
TSL:1
c.982-5093T>C
intron
N/AENSP00000437634.1P09917-2
ALOX5
ENST00000851643.1
c.1018-5093T>C
intron
N/AENSP00000521702.1

Frequencies

GnomAD3 genomes
AF:
0.755
AC:
114318
AN:
151436
Hom.:
43685
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.865
Gnomad AMI
AF:
0.678
Gnomad AMR
AF:
0.777
Gnomad ASJ
AF:
0.666
Gnomad EAS
AF:
0.733
Gnomad SAS
AF:
0.610
Gnomad FIN
AF:
0.763
Gnomad MID
AF:
0.766
Gnomad NFE
AF:
0.700
Gnomad OTH
AF:
0.741
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.755
AC:
114437
AN:
151554
Hom.:
43743
Cov.:
29
AF XY:
0.753
AC XY:
55749
AN XY:
74006
show subpopulations
African (AFR)
AF:
0.865
AC:
35713
AN:
41284
American (AMR)
AF:
0.777
AC:
11857
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.666
AC:
2314
AN:
3472
East Asian (EAS)
AF:
0.733
AC:
3787
AN:
5166
South Asian (SAS)
AF:
0.610
AC:
2920
AN:
4790
European-Finnish (FIN)
AF:
0.763
AC:
7930
AN:
10388
Middle Eastern (MID)
AF:
0.786
AC:
231
AN:
294
European-Non Finnish (NFE)
AF:
0.700
AC:
47514
AN:
67898
Other (OTH)
AF:
0.740
AC:
1558
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1353
2706
4060
5413
6766
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
842
1684
2526
3368
4210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.726
Hom.:
22025
Bravo
AF:
0.763
Asia WGS
AF:
0.701
AC:
2439
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.20
DANN
Benign
0.67
PhyloP100
-3.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4540799;
hg19: chr10-45930785;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.